CDC-RFA-PS21-2107: Development of a COVID-19 Monitoring System for U.S. Correctional and Detention Facilities
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCHHSTP notices from 2021.
Centers for Disease Control - NCHHSTP offered grants to the applicants described in the notice. It expected to make one award worth $970,550 in total. Applications closed on March 31, 2021.
From the official notice on Grants.gov, last changed March 25, 2021. Checked November 7, 2026.
- Total funding$970,550
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 1, 2021 |
|---|---|
| Deadline | March 31, 2021 |
| Archived by Grants.gov | April 30, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
The National Sheriffs’ Association
Is this a realistic fit?
- Most of the program's money (39% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
Persons experiencing incarceration are disproportionately affected by coronavirus disease 2019 (COVID-19). Correctional environments have demonstrated the potential for rapid spread of SARS-CoV-2 (the virus that causes COVID-19), high attack rates, and high mortality rates. SARS-CoV-2 can be introduced into correctional/detention facilities through numerous routes, including staff who move between the facility and the community, as well as newly incarcerated/detained persons and those who are transferred between facilities. Inside the facility, SARS-CoV-2 transmission can often be rapid and widespread due to congregate living conditions and limited capacity for physical and social distancing. Transmission between facilities during transfers has been documented in numerous states, sometimes initiating outbreaks in facilities that previously had no cases. In addition to the risks to incarcerated/detained populations and staff working in these facilities, transmission within and among correctional and detention facilities poses a risk to the communities where the facilities are located. Although incarcerated/detained persons cannot move freely, the facilities where they are held are not closed systems; preventing and slowing SARS-CoV-2 transmission within and among correctional and detention facilities will also contribute to the prevention and slowing of community transmission. There is currently no comprehensive data system allowing correctional and detention facilities under the jurisdiction of different federal, state, and local entities to share information related to SARS-CoV-2 in their populations in a direct and secure manner. This Cooperative Agreement will fund the development and pilot implementation of such a system, in order to facilitate communication a) between facilities regarding cross-jurisdictional COVID-19 prevention and b) with public health entities including state and local health departments and CDC. In the future, this data system could be expanded to include other infectious and chronic diseases and behavioral health conditions within correctional and detention populations, in order to improve public health reporting and to facilitate coordination, collaboration, and technical assistance during future public health emergencies as well as routine operations.
Who has won Centers for Disease Control and Prevention Investigations and Technical Assistance grants before
From fiscal 2021 to 2025, Centers for Disease Control and Prevention Investigations and Technical Assistance (93.283) awarded $1.7 billion across 1,365 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Unicef | New York | 2 | $83.3 million |
| World Health Organization, Somalia | 6 | $74.5 million | |
| African Field Epidemiology Network LTD | 6 | $64.2 million | |
| International Organization for Migration | District of Columbia | 3 | $45.0 million |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 6 | $36.5 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-PS21-2107 still open?
No. It closed on March 31, 2021.
Who can apply for Development of a COVID-19 Monitoring System for U.S. Correctional and Detention Facilities?
Centers for Disease Control - NCHHSTP accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Development of a COVID-19 Monitoring System for U.S. Correctional and Detention Facilities?
Closed March 31, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $970,550 in total for one award.
Who has won Centers for Disease Control and Prevention Investigations and Technical Assistance grants before?
The largest recipients over five fiscal years were Unicef, World Health Organization, Somalia, African Field Epidemiology Network LTD. The program made 1,365 awards worth $1.7 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)